To date, however, evidence is particularly sound in sustaining the anti-inflammatory activity of resveratrol, over the others natural molecules, to counteract the proliferation of CRC (69) and MCF-7 breast cancer cell line, via p53-COX-2 pathway (70). This evidence concerns the gene PTGS2 and breast carcinoma.